[1]
Tawil R.: Facioscapulohumeral muscular dystrophy. Neurotherapeutics
2008; 5(4): 601–606.
[2]
Sacconi S., Salviati L., Desnuelle C.: Facioscapulohumeral muscular
dystrophy. Biochim Biophys Acta 2015; 1852(4): 607–614.
[3]
Aprile I., Bordieri C., Gilardi A., et al.: Balance and walking involvement
in facioscapulohumeral dystrophy: a pilot study on the effects of custom
lower limb orthoses. Eur J Phys Rehabil Med 2013; 49(2): 169–178.
[4]
Wohlgemuth M., van der Kooi E. L., van Kesteren R. G., et al.: Ventilatory
support in facioscapulohumeral muscular dystrophy. Neurology 2004
vol. 63 no. 1: 176–178.
[5]
Lutz K. L., Holte L., Kliethermes S. A., et al.: Clinical and genetic features
of hearing loss in facioscapulohumeral muscular dystrophy. Neurology
2013; 81(16): 1374–1377.
[6]
Rogers M. T., Zhao F., Harper P. S., et al.: Absence of hearing impairment
in adult onset facioscapulohumeral muscular dystrophy. Neuromuscul
Disord 2002; 12(4): 358–365.
[7]
Statland J. M., Sacconi S., Farmakidis C., et al.: Coats syndrome in
facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction
size. Neurology 2013; 80(13): 1247–1250.
[8]
Fitzsimons R. B., Gurwin E. B., Bird A. C.: Retinal vascular abnormalities
in facioscapulohumeral muscular dystrophy. A general association with
genetic and therapeutic implications. Brain Jun 1987; 110 (Pt 3): 631–
648.
[9]
van Dijk G. P., van der Kooi E., Behin A., et al.: High prevalence of
incomplete right bundle branch block in facioscapulohumeral muscular
dystrophy without cardiac symptoms. Funct Neurol 2014; 29(3): 159–
165.
[10]
Groh, W. J.: Arrhythmias in the muscular dystrophies. Heart Rhythm
2012; 9(11): 1890–1895.
[11]
Shen E. N., Madsen T.: Facioscapulohumeral muscular dystrophy and
recurrent pacemaker lead dislodgement. Am Heart J 1991; 122(4 Pt 1):
1167–1169.
[12]
Tawil R., Kissel J. T., Heatwole C., et al.: Evidence-based
guideline summary: Evaluation, diagnosis, and management of
facioscapulohumeral muscular dystrophy: Report of the Guideline
Development, Dissemination, and Implementation Subcommittee of the
American Academy of Neurology and the Practice Issues Review Panel
of the American Association of Neuromuscular & Electrodiagnostic
Medicine. Neurology 2015; 85(4): 357–364.
[13]
Mul K., Padberg G. W., Voermans N. C.: Facioscapulohumeral muscular
dystrophy as a genetic cause of pectus excavatum. Eur J Med Genet
2015; 58(4): 203–204.
[14]
Wohlgemuth M., de Swart B. J., Kalf J. G., et al.: Dysphagia in
facioscapulohumeral muscular dystrophy. Neurology 2006; 66(12):
1926–1928.
[15]
Bindoff L. A., Mjellem N., Sommerfelt K., et al.: Severe
fascioscapulohumeral muscular dystrophy presenting with Coats’
disease and mental retardation. Neuromuscul Disord 2006; 16(9–10):
559–563.
[16]
Mul K., Lassche S., Voermans N. C., et al.: What’s in a name? The clinical
features of facioscapulohumeral muscular dystrophy. Pract Neurol 2016,
pii: practneurol-2015-001353. doi: 10.1136/practneurol-2015-001353.
[17]
Dorobek M., Szmidt-Sałkowska E., Rowińska-Marcińska K., et al.:
Relationships between clinical data and quantitative EMG findings in
facioscapulohumeral muscular dystrophy. Neurol Neurochir Pol 2013;
47(1): 8–17.
[18]
Fitzsimons R. B.: Retinal vascular disease and the pathogenesis of
facioscapulohumeral muscular dystrophy. A signalling message from
Wnt? Neuromuscul Disord 2011; 21(4): 263–271.
[19]
Dahlqvist J. R., Vissing C. R., Thomsen C., et al.: Severe paraspinal
muscle involvement in facioscapulohumeral muscular dystrophy.
Neurology 2014; 83(13): 1178–1183.
[20]
Rijken N. H., van Engelen B. G., de Rooy J. W., et al.: Trunk muscle
involvement is most critical for the loss of balance control in patients
with facioscapulohumeral muscular dystrophy. Clin Biomech 2014;
29(8): 855–860.
[21]
Tasca G., Monforte M., Ottaviani P., et al.: Magnetic Resonance Imaging
in a Large Cohort of Facioscapulohumeral Muscular Dystrophy Patients:
Pattern Refinement and Implications for Clinical Trials. Ann Neurol 2016,
doi: 10.1002/ana.24640.
[22]
Lemmers R. J., Wohlgemuth M., van der Gaag K. J., et al.: Specific
sequence variations within the 4q35 region are associated with
facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81(5):
884–894.
[23]
Gaillard M. C., Roche S., Dion C., et al.: Differential DNA methylation
of the D4Z4 repeat in patients with FSHD and asymptomatic carriers.
Neurology 2014; 83(8): 733–742.
[24]
Lemmers R. J., van der Vliet P. J., Klooster R., et al.: A unifying genetic
model for facioscapulohumeral muscular dystrophy. Science 2010;
329(5999): 1650–1653.
[25]
Lemmers R. J., O’Shea S., Padberg G. W., et al.: Best practice guidelines
on genetic diagnostics of Facioscapulohumeral muscular dystrophy:
workshop 9th June 2010, LUMC, Leiden, The Netherlands. Neuromuscul
Disord 2012; 22(5): 463–470.
[26]
Sacconi S., Lemmers R. J., Balog J., et al.: The FSHD2 gene SMCHD1 is
a modifier of disease severity in families affected by FSHD1. Am J Hum
Genet 2013; 93(4): 744–751.
[27]
Tawil R., Forrester J., Griggs R. C., et al.: Evidence for anticipation
and association of deletion size with severity in facioscapulohumeral
muscular dystrophy. The FSH-DY Group. Ann Neurol 1996; 39(6): 744–
748.
[28]
Zatz M., Marie S. K., Cerqueira A., et al.: The facioscapulohumeral
muscular dystrophy (FSHD1) gene affects males more severely and
more frequently than females. Am J Med Genet 1998; 77(2): 155–161.
[29]
Flanigan K. M., Coffeen C. M., Sexton L., et al.: Genetic characterization
of a large, historically significant Utah kindred with facioscapulohumeral
dystrophy. Neuromuscul Disord 2001; 11(6-7): 525–529.
[30]
Passerieux E., Hayot M., Jaussent A., et al.: Effects of vitamin C,
vitamin E, zinc gluconate, and selenomethionine supplementation
on muscle function and oxidative stress biomarkers in patients with
facioscapulohumeral dystrophy: A double-blind randomized controlled
clinical trial Free Radic Biol Med 2015; 81:158–69.
[31]
Voet N., Bleijenberg G., Hendriks J., et al.: Both aerobic exercise and
cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT.
Neurology 2014; 83(21): 1914–1922.
[32]
Tawil R., van der Maarel S. M., Tapscott S. J.: Facioscapulohumeral
dystrophy: the path to consensus on pathophysiology. Skelet Muscle
2014; 4: 12.
Scholar Google
PubMed